Home
 > 
Resources
 > 
Actualités et communiqués de presse
 > 
PPTA Statement on FDA Guidance Documents

PPTA Statement on FDA Guidance Documents

PPTA news cover with the title written

PPTA is aware of the guidance documents released by the U.S. Food and Drug Administration on April 2 regarding Source plasma donor eligibility and is currently evaluating them.

Our focus remains, as it has for nearly three decades, on patient and donor safety, and the safety of therapies derived from plasma.

‍

Created on April 03 2020.